Agilent
Reasons to be Testing: Transitioning Complex Cancer Genomics into Routine Oncology Practice
Through the delivery of projects including TCGA and ICGC, the lexicon of cancer genomics is nearing completion. Unlocking this knowledge to improve patient outcomes now requires embedding comprehensive genomic profiling into routine oncology practice.
Dr. Philip Beer
Physician-scientist and precision oncology specialist, Yes
Dr. Susie Cook
Head of Medical Genomics, UK
Register for webinar
Dr. Philip Beer, Dr. Susie Cook
Reasons to be Testing: Transitioning Complex Cancer Genomics into Routine Oncology Practice
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
